Parkinson's disease progression may be driven by an overlooked cellular communication network that actively spreads toxic protein aggregates between brain cells. This discovery challenges the prevailing view that neurodegeneration in Parkinson's is primarily a cell-internal process, revealing instead a destructive feedback loop that could be therapeutically targeted.
The research identifies glycoprotein nonmetastatic melanoma B (GPNMB) as a key facilitator in the spread of alpha-synuclein pathology, the protein clumps that define Parkinson's disease. When neurons die, nearby microglia—the brain's immune cells—respond by increasing GPNMB production and secretion. This secreted GPNMB then enhances the uptake of toxic alpha-synuclein fibrils by healthy neurons, even those lacking GPNMB entirely. Analysis of 1,675 human brain samples confirmed that genetic variants producing higher GPNMB levels correlate with more extensive alpha-synuclein pathology.
This mechanism represents a previously unrecognized positive feedback loop: neuronal death triggers microglial GPNMB release, which accelerates alpha-synuclein spread to additional neurons, causing further cell death and more GPNMB secretion. The finding transforms our understanding of Parkinson's progression from a series of independent cellular failures to a coordinated intercellular process. Critically, anti-GPNMB antibodies successfully blocked this pathological cycle in laboratory models, suggesting a clear therapeutic pathway. While most Parkinson's research has focused on protecting individual neurons or clearing protein aggregates, targeting the GPNMB-mediated communication system could interrupt disease progression at its source. This represents a shift toward treating Parkinson's as a disorder of cellular communication rather than isolated neuronal dysfunction.